Next Article in Journal / Special Issue
Japan’s Ongoing Crisis on HPV Vaccination
Previous Article in Journal
Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth
Previous Article in Special Issue
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus

Prospects and Challenges in the Development of Universal Influenza Vaccines

Influenza Centre, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
Department of Microbiology, Haukeland University Hospital, 5021 Bergen, Norway
Author to whom correspondence should be addressed.
Vaccines 2020, 8(3), 361;
Received: 5 June 2020 / Revised: 29 June 2020 / Accepted: 30 June 2020 / Published: 6 July 2020
(This article belongs to the Special Issue Development of Cross-Protective Vaccines)
Current influenza vaccines offer suboptimal protection and depend on annual reformulation and yearly administration. Vaccine technology has rapidly advanced during the last decade, facilitating development of next-generation influenza vaccines that can target a broader range of influenza viruses. The development and licensure of a universal influenza vaccine could provide a game changing option for the control of influenza by protecting against all influenza A and B viruses. Here we review important findings and considerations regarding the development of universal influenza vaccines and what we can learn from this moving forward with a SARS-CoV-2 vaccine design. View Full-Text
Keywords: influenza; vaccine; next-generation vaccine influenza; vaccine; next-generation vaccine
Show Figures

Figure 1

MDPI and ACS Style

Madsen, A.; Cox, R.J. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines 2020, 8, 361.

AMA Style

Madsen A, Cox RJ. Prospects and Challenges in the Development of Universal Influenza Vaccines. Vaccines. 2020; 8(3):361.

Chicago/Turabian Style

Madsen, Anders, and Rebecca Jane Cox. 2020. "Prospects and Challenges in the Development of Universal Influenza Vaccines" Vaccines 8, no. 3: 361.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop